Evidence map›Paper›PMID 41095547›Full record

ArticleHealthcare (Basel, Switzerland)2025

Win-Win Pricing of Follow-Up Policies Under Healthcare Warranties for Chronic Diseases: A Mathematical Modeling Approach.

Mei Li, Zixian Liu, Lijun Liang

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mei LiSchool of Management, Xi'an University of Architecture and Technology, Xi'an 710055, China.
Zixian LiuCollege of Management & Economics, Tianjin University, Tianjin 300072, China.
Lijun LiangSchool of Management, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.ORCID 0000-0002-0058-4064

Funding

National Natural Science Foundation of China 72104180, 72342017, and 72374166Natural Science Basis Research Plan in Shaanxi Province of China 2025JC-YBQN-1014
6 · The paper itself

Abstract

Implementing follow-up policies under healthcare warranties for chronic disease patients plays a crucial role in reducing the risk of adverse outcomes (AOs) and controlling long-term medical costs. However, the additional cost associated with these services often discourages hospitals from providing them.

Indexed as

chronic diseasefollow-up policyhealthcare managementhealthcare warrantymedical decision makingwin-win price interval

Identifiers

PMID41095547
PMCPMC12523621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.